New cancer drugs release the brakes on the immune systemEarly trials of immunotherapy mark ‘new chapter’ in oncology Guidelines for prevention of acute antineoplastic-induced nausea and vomiting in childrenPediatric Oncology Group of Ontario spearheads development of guidelines for the prevention of acute antineoplastic-induced nausea and vomiting in children. CUA: Testosterone level should guide androgen deprivation therapy Analysis shows importance of reaching low values CUA: Prostate inflammation cuts cancer risk Finding has implications for biopsy followup CUA: Survey reveals gaps in genitourinary cancer survivorship care CUA: A new way to zap the prostate—MRI-guided laser ablation Outpatient procedure has low morbidity but high failure rate Xtandi: new oral androgen receptor inhibitor for metastatic prostate cancer Drug is intended for patients who have undergone medical or surgical castration and who have received docetaxel therapy. U.S. guideline nixes prostate screening in under-55s Prostate cancer: More men can opt for active surveillance All conventional criteria need not be fulfilled, analysis shows Late toxicities of cancer drugs Cardiac, pulmonary, sexual, and neurologic toxicities that develop or persist after completing cancer drug therapy First Previous 37 38 39 40 41 Next Last
